Cardiology News

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced that Dr. Jonathan Alis, Dr. Seth I. Sokol and their team at Jacobi Hospital in Bronx, New York have been selected as an ALPHA-PE Research Fund award recipients. The independent, investigator-led study, supported in partnership with The PERT C...

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced that the U.S. Food and Drug Administration (FDA) has approved the AUTUS Size-Adjustable Valve, a surgical pulmonary valve designed specifically for pediatric patients with congenital heart disease who require pulmonary valve replacement. For many pediatric patients, pulmonary valve replacement is not a one-time event. The AUTUS valve is the first FDA-approved surgical pulmonary valve designed for pediatric anatomy,...

BRATISLAVA, Slovakia--(BUSINESS WIRE)--Powerful Medical, developer of the PMcardio AI cardiology platform, and corpuls, Europe's leading manufacturer of monitor/defibrillator systems for prehospital emergency medical services, today announced a strategic partnership to integrate Powerful Medical's Queen of Hearts AI ECG model directly into the corpuls platform used by emergency care professionals in over 70 countries globally. Health care professionals recording a 12-lead ECG on a corpuls3 devi...

CARROLLTON, Ga--(BUSINESS WIRE)--Patients with suspected heart attacks across west Georgia and east Alabama will now have access to artificial intelligence-powered electrocardiogram (ECG) assessment whether their first medical contact occurs in a 911 ambulance, a community hospital or a cardiac center, following Tanner Health's deployment of Powerful Medical's PMcardio platform. The rollout marks the first commercial United States deployment of Queen of Hearts, Powerful Medical's newly FDA-auth...

COLUMBIA, Md.--(BUSINESS WIRE)--Welldoc®, a leader in AI-powered health technology for complex conditions, today launched its next-generation platform: a digital-first care loop connecting an individual’s daily health experience directly to their care team. Unlike consumer chatbots, the care loop runs on Welldoc’s clinically validated Small Language Models (SLMs), ensuring guidance is personalized, measurable, and connected to a clinician. At its center is Simon, Welldoc’s AI care agent, orchest...

MENLO PARK, Calif.--(BUSINESS WIRE)--Inquis Medical, a medical device company pioneering advanced treatments for venous thromboembolic disease, today announced the U.S. commercial launch of the latest AVENTUS™ Catheter, designed to provide physicians with 360° sweeping directional aspiration for clot removal within the vasculature. Austin Bourgeois, MD, performed the first-in-human pulmonary embolism (PE) procedure using the new catheter at Huntsville Hospital in Huntsville, Alabama. AVENTUS is...

BRENTWOOD, Tenn.--(BUSINESS WIRE)--SpecialtyCare, the nation's leading provider of outsourced clinical services, announced today that its Intraoperative Neuromonitoring (IONM) Training Program has earned accreditation from the Commission on Accreditation of Allied Health Education Programs (CAAHEP). This prestigious accreditation underscores SpecialtyCare's commitment to providing high-quality education and training that meets the national quality assurance standards established by CAAHEP. CAAH...

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke, today announced that it will host a virtual key opinion leader (KOL) event on October 23, 2026 at 8:00am Eastern Time to discuss fetal growth restriction (FGR), the therapeutic rationale for evaluating DM199 (rinvecalinase alfa) as a potential treatment for FGR and prelimi...

HEIDELBERG, Germany--(BUSINESS WIRE)--Hummingbird Diagnostics will present blood-based RNA biomarker data on prognosis and potential MRD assessment in stage III lung cancer at ESMO 2026....

SOUTH SAN FRANCISCO, Calif. & PRINCETON, N.J.--(BUSINESS WIRE)--Kardigan announced today the appointment of Kristin Reinke to its Board of Directors, where she will serve as chair of the Audit Committee....